Physicians' Life

Top Story

American Cancer Society creates blueprint to reduce cancer mortality by 2035

American Cancer Society creates blueprint to reduce cancer mortality by 2035
July 10, 2018
Meeting News

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process

November 16, 2017
WASHINGTON — When diagnosed with Hodgkin lymphoma at…

Stephen M. Ansell, MD, PhD: Translational scientist at heart

January 18, 2017
Stephen M. Ansell, MD, PhD, is professor of medicine at Mayo Clinic in Rochester, Minnesota. He is chair of the Mayo Clinic Lymphoma Group and chair of the scientific…

David H. Ilson, MD, PhD: International traveler and art history enthusiast

December 22, 2016
David H. Ilson, MD, PhD, is a medical oncologist at Memorial Sloan Kettering Cancer Center and a HemOnc Today Editorial Board member. His clinical interests and…
More Headlines »

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

The integration of immune checkpoint inhibitors into treatment algorithms for patients with bladder cancer who have…
More »
Meeting News

VIDEO: Telemedicine viable option for patients seeking efficient ways to receive health care

August 15, 2018
More »
Resource Centers
Immuno-Oncology Resource Center

Immuno-Oncology Resource Center


Ace the Case: A 72-Year-Old Man With Fatigue, Weight Loss, and Lymphocytosis

There is no commercial support for this activity.

This educational activity will review the diagnosis and management of a 72-year-old man with complaints of increasing…
More »